Bli medlem
Bli medlem

Du är här


Mentice AB: Mentice receives order of total SEK 7.0 million from Edwards Lifesciences

Mentice receives order from Edwards Lifesciences (EW) (Irvine, CA) relating to development and systems providing training solutions to support EW in safe roll-out of medical device solutions for the mitral and tricuspid valve therapy areas. 

The order will be accounted for in the order book for the segment Medical Device Industry during the third quarter 2020. The total value for the order amounts to SEK 7.0 million to be delivered during the fourth quarter 2020.

For more information, please contact:
Göran Malmberg, CEO, Mentice

US Mobile. +1 (312) 860 5610

Sweden Mobile +46 (0) 703 09 22 22

This information is information that Mentice AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person, at 10.00 on July 16, 2020.  

Marketplace| Nasdaq First North Premier, Stockholm | Ticker symbol MNTC

Certified Adviser| FNCA Sweden AB, phone +46 8 528 00 399

Författare Mentice AB

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.